Trump tests MAHA support with glyphosate move
The Hill
by Rachel FrazinFebruary 25, 2026
AI-Generated Deep Dive Summary
President Trump's recent environmental policies have created significant tension with his "Make America Healthy Again" (MAHA) allies, particularly following an executive order that praised and provided legal protections for glyphosate, a herbicide embroiled in litigation. This move has angered MAHA activists, who were already frustrated by simmering disagreements over prior environmental decisions. Trump's actions have now tested the boundaries of his alliance with MAHA, potentially weakening their support for his administration.
The executive order offering "immunity" to glyphosate producers and users has been met with strong criticism from environmental groups and public health advocates. Glyphosate, commonly known as Roundup, has faced legal challenges due to concerns over its potential health risks, including links to cancer. Activists argue that Trump's decision prioritizes corporate interests over public safety, further alienating MAHA supporters who view him as backtracking on environmental protections.
Tensions between the administration and MAHA were already high due to previous policy disputes, including rollbacks of environmental regulations and decisions that activists perceive as neglecting public health. The glyphosate controversy has intensified these divisions, with MAHA leaders accusing Trump of undermining efforts to promote environmentally sustainable practices. This growing rift highlights the challenges Trump faces in maintaining alliances with groups that once supported his agenda.
The significance of this conflict lies in its potential impact on Trump's political strategy and the broader implications for environmental policy under his administration. By alienating MAHA, Trump may be jeopardizing his ability to push through other initiatives, particularly those reliant on bipartisan cooperation or public health coalitions. The situation also underscores ongoing debates over corporate responsibility, public safety, and the role of government in regulating harmful substances.
Ultimately, Trump's decision to champion glyphosate despite its controversial reputation has placed his environmental agenda under greater scrutiny. This development not only reflects internal divisions within his coalition but also raises questions about the administration's commitment to addressing pressing environmental and health concerns. The outcome of this tension will likely shape future policy decisions and the credibility of both Trump and MAHA in the eyes of the public.
Verticals
politicsnews
Originally published on The Hill on 2/25/2026